Novome Biotechnologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.novomebio.com
Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects
Phase 1
Terminated
- Conditions
- Healthy VolunteersEnteric Hyperoxaluria
- Interventions
- First Posted Date
- 2021-06-02
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Novome Biotechnologies Inc
- Target Recruit Count
- 153
- Registration Number
- NCT04909723
- Locations
- 🇺🇸
Indiana University, Carmel, Indiana, United States
🇺🇸Clinical Research Solutions, Cleveland, Ohio, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath